Expression of α-synuclein in the human brain: Relation to Lewy body disease

Molecular Brain Research

Volumn 92, Issue 1-2, 2001, Pages 58-65

  Wirdefeldt, Karin ^a   Bogdanovic, Nenad ^a   Westerberg, Lisa ^a   Payami, Haydeh ^b   Schalling, Martin ^a   Murdoch, Geoffrey ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Synuclein; Gene expression; In situ hybridization; Lewy body disease; mRNA; Parkinson disease

Indexed keywords

ALPHA SYNUCLEIN; BETA TUBULIN; MESSENGER RNA;

AGED; ARTICLE; BRAIN; BRAIN NERVE CELL; CELL LOSS; CINGULATE GYRUS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LEWY BODY; MALE; MUTATION; NERVE CELL DEGENERATION; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; FEMALE; FRONTAL LOBE; GYRUS CINGULI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IN SITU HYBRIDIZATION; LEWY BODIES; LEWY BODY DISEASE; MALE; NERVE TISSUE PROTEINS; NEUROFIBRILLARY TANGLES; PYRAMIDAL CELLS; RNA, MESSENGER; SENILE PLAQUES; SYNUCLEINS; TUBULIN;

MUS MUSCULUS;

EID: 0035882344     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(01)00150-4     Document Type: Article

References (44)

1. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy
2. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
3. Neural expression profile of α-synuclein in developing human cortex
4. Epidemiologic approaches to the study of Parkinson's disease etiology
5. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease
6. Widespread alterations of alpha-synuclein in multiple system atrophy
7. The expression of α-, β-, and γ-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases
8. Neuropathology of synuclein aggregates: New insights into mechanisms of neurodegenerative diseases
9. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies
10. Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease
11. Synucleinopathies: Clinical and pathological implications
12. Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro
13. Protein nitration in Parkinson's disease
14. The new stereological tools: Dissector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis
15. Genetic classification of primary neurodegenerative disease
16. Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with lewy bodies
17. Expression pattern of synucleins (non-A beta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development
18. The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system
19. Identification of two distinct synucleins from human brain
20. Oxidative mechanisms in nigral cell death in Parkinson's disease
21. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation
22. Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury
23. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease
24. Involvement of α-synuclein in Parkinson's disease and other neurodegenerative disorders
25. Oxidative damage to proteins, lipids and DNA in cortical brain regions from patients with dementia with Lewy bodies
26. Reduced expression of the G209A α-synuclein allele in familial parkinsonism
27. Dopaminergic loss and inclusion body formation in α-synuclein mice: Implications for neurodegenerative disorders
28. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
29. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease
30. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
31. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation
32. α-Synuclein expression in substantia nigra and cortex in Parkinson's disease
33. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly
34. Developmental expression of alpha-synuclein in rat hippocampus and cerebral cortex
35. Mutation in the α-synuclein gene identified in families with Parkinson's disease
36. Dementia with Lewy bodies: Prevalence, clinical spectrum and natural history
37. Neuropeptide Y and catecholamine synthesizing enzymes and their mRNAs in rat sympathetic neurons and adrenal glands: Studies on expression, synthesis and axonal transport after pharmacological and experimental manipulations using hybridization techniques and radioimmunoassay
38. Expression of α-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: Genes associated with familial Parkinson's disease
39. Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies
40. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies
41. Glial cytoplasmatic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein
42. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease
43. Cortical Lewy body-containing neurons are pyramidal cells: Laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32
44. α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy